Paragon Capital Management LTD Abbott Laboratories Transaction History

Paragon Capital Management LTD

$487 Million
Q3 2024

A detailed history of Paragon Capital Management LTD transactions in Abbott Laboratories stock. As of the latest transaction made, Paragon Capital Management LTD holds 6,281 shares of ABT stock, worth $719,111. This represents 0.15% of its overall portfolio holdings.

Number of Shares

6,281

Previous 6,554 4.17%

Holding current value

$719,111

Previous $681,000 5.14%

% of portfolio

0.15%

Previous 0.13%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$100.07 - $118.13 $27,319 - $32,249	-273 Reduced 4.17%	6,281 $716,000
Q2 2024 Jul 12, 2024	BUY	$100.73 - $112.44 $302 - $337	3 Added 0.05%	6,554 $681,000
Q1 2024 Apr 11, 2024	BUY	$109.52 - $120.96 $219 - $241	2 Added 0.03%	6,551 $744,000
Q4 2023 Jan 12, 2024	BUY	$90.19 - $110.4 $180 - $220	2 Added 0.03%	6,549 $720,000
Q3 2023 Oct 10, 2023	SELL	$95.53 - $114.62 $18,914 - $22,694	-198 Reduced 2.94%	6,547 $634,000
Q2 2023 Jul 11, 2023	SELL	$100.78 - $112.29 $66,212 - $73,774	-657 Reduced 8.88%	6,745 $735,000
Q1 2023 Apr 13, 2023	SELL	$96.86 - $114.01 $43,393 - $51,076	-448 Reduced 5.71%	7,402 $749,000
Q4 2022 Jan 17, 2023	BUY	$95.06 - $111.52 $190 - $223	2 Added 0.03%	7,850 $0
Q3 2022 Oct 14, 2022	SELL	$96.76 - $112.03 $43,445 - $50,301	-449 Reduced 5.41%	7,848 $759,000
Q2 2022 Jul 18, 2022	SELL	$102.07 - $123.37 $55,934 - $67,606	-548 Reduced 6.2%	8,297 $901,000
Q1 2022 Apr 19, 2022	SELL	$114.02 - $139.04 $16,874 - $20,577	-148 Reduced 1.65%	8,845 $1.05 Million
Q4 2021 Jan 27, 2022	BUY	$115.53 - $141.46 $115 - $141	1 Added 0.01%	8,993 $1.27 Million
Q3 2021 Oct 19, 2021	SELL	$116.66 - $129.06 $22,515 - $24,908	-193 Reduced 2.1%	8,992 $1.06 Million
Q2 2021 Jul 29, 2021	BUY	$105.79 - $124.53 $211 - $249	2 Added 0.02%	9,185 $1.07 Million
Q1 2021 Apr 21, 2021	BUY	$108.84 - $128.23 $108 - $128	1 Added 0.01%	9,183 $1.1 Million
Q4 2020 Jan 26, 2021	SELL	$105.0 - $114.42 $735 - $800	-7 Reduced 0.08%	9,182 $1.01 Million
Q3 2020 Oct 22, 2020	BUY	$91.64 - $111.29 $91 - $111	1 Added 0.01%	9,189 $1 Million
Q2 2020 Jul 27, 2020	BUY	$76.57 - $98.0 $703,525 - $900,424	9,188 New	9,188 $840,000
Q1 2020 Apr 29, 2020	SELL	$62.82 - $91.86 $576,938 - $843,642	-9,184 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$78.51 - $87.4 $78 - $87	1 Added 0.01%	9,184 $798,000
Q3 2019 Oct 18, 2019	BUY	$81.84 - $88.74 $163 - $177	2 Added 0.02%	9,183 $768,000
Q2 2019 Jul 23, 2019	BUY	$72.88 - $85.0 $145 - $170	2 Added 0.02%	9,181 $772,000
Q1 2019 May 01, 2019	BUY	$66.22 - $80.06 $66 - $80	1 Added 0.01%	9,179 $734,000
Q4 2018 Jan 29, 2019	SELL	$65.56 - $74.27 $2,884 - $3,267	-44 Reduced 0.48%	9,178 $664,000
Q3 2018 Nov 05, 2018	BUY	$60.81 - $73.36 $9,851 - $11,884	162 Added 1.79%	9,222 $677,000
Q1 2018 Apr 24, 2018	SELL	$56.27 - $63.62 $63,697 - $72,017	-1,132 Reduced 11.11%	9,060 $543,000
Q3 2017 Oct 26, 2017	BUY	$48.06 - $53.64 $489,827 - $546,698	10,192	10,192 $544,000

Others Institutions Holding ABT

# of Institutions

3,164

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.19M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Paragon Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Paragon Capital Management LTD with notifications on news.

Account

Paragon Capital Management LTD Abbott Laboratories Transaction History